COVID-19 Linked to Increased Risk for DVT, PE, Bleeding
FRIDAY, April 8, 2022 -- COVID-19 is associated with an increased risk for deep vein thrombosis, pulmonary embolism, and bleeding, according to a study published online April 6 in The BMJ. Ioannis Katsoularis, M.D., from Umeå University in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 8, 2022 Category: Pharmaceuticals Source Type: news

Post-COVID Risk for Blood Clot Lasts at Least 6 Months
New findings suggest COVID-19 is an independent risk factor for deep vein thrombosis, pulmonary embolism and bleeding. (Source: WebMD Health)
Source: WebMD Health - April 7, 2022 Category: Consumer Health News Source Type: news

Covid linked to 33-fold increase in risk of potentially fatal blood clot
Infection with virus also associated with fivefold increase in risk of deep vein thrombosis, data suggestsCatching Covid is associated with a fivefold increase in the risk of deep vein thrombosis (DVT) and a 33-fold increase in risk of a potentially fatal blood clot on the lung in the 30 days after becoming infected, data suggests.The findings,published in the British Medical Journal on Thursday, could help explain a doubling in the incidence of, and deaths from, blood clots in England since the start of the pandemic compared with the same periods in 2018 and 2019.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 6, 2022 Category: Science Authors: Linda Geddes Tags: Coronavirus World news Science Infectious diseases Microbiology Medical research Health Society Source Type: news

Covid linked to 33-fold increase in risk of pulmonary embolism
Infection with virus also associated with fivefold increase in risk of deep vein thrombosis, data suggestsCatching Covid is associated with a fivefold increase in the risk of deep vein thrombosis (DVT) and a 33-fold increase in risk of a potentially fatal blood clot on the lung in the 30 days after becoming infected, data suggests.The findings,published in the British Medical Journal on Thursday, could help explain a doubling in the incidence of, and deaths from, blood clots in England since the start of the pandemic compared with the same periods in 2018 and 2019.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 6, 2022 Category: Science Authors: Linda Geddes Tags: Coronavirus World news Science Infectious diseases Microbiology Medical research Health Society Source Type: news

Small Leaks After LAAO Linked to Thromboembolism, Bleeding Small Leaks After LAAO Linked to Thromboembolism, Bleeding
The findings are in line with recent data, but the discovery of increased major bleeding came as a surprise in this large registry analysis of more than 50,000 patients.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 6, 2022 Category: Cardiology Tags: Cardiology News Source Type: news

Anticoagulation Goes Head-to-Head With DAPT After Valve Surgery
(MedPage Today) -- WASHINGTON -- In an open-label, randomized study, treatment with the direct oral anticoagulant edoxaban was not significantly more efficient in preventing complications of leaflet thrombosis following transcatheter aortic-valve... (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - April 6, 2022 Category: Radiology Source Type: news

Anticoagulation Not Routinely Needed After TAVR: ADAPT-TAVR Anticoagulation Not Routinely Needed After TAVR: ADAPT-TAVR
The ADAPT-TAVR trial showed a numerical reduction in leaflet thrombosis with edoxaban versus dual antiplatelet therapy, but no reduction in cerebral events or neurocognitive functionMedscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 4, 2022 Category: Cardiology Tags: Cardiology News Source Type: news

Data from New VOYAGER PAD Analyses at ACC.22 Reinforce Benefit of XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Peripheral Artery Disease (PAD) and Various Co-Morbid Conditions
RARITAN, N.J., April 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from new analyses from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefit of the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) in reducing severe vascular events in patients with PAD after lower-extremity revascularization (LER), a procedure that restores blood flow to the legs. Data from the two analyses demonstrate the role that the XARELTO® vascular dose plays in PAD patients with and without chronic kidney disease (CKD) and in PAD patients with and ...
Source: Johnson and Johnson - April 1, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Is Aspirin the Best Way to Prevent Blood Clots After THA/TKA? Is Aspirin the Best Way to Prevent Blood Clots After THA/TKA?
Patients discharged to facilities rather than home may need more aggressive agents to prevent venous thromboembolism.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 29, 2022 Category: Consumer Health News Tags: Orthopaedics News Source Type: news

Blood clots: Expert shares 'key warning signs' of potential life-threatening DVT
A BLOOD clot in the vein, usually in the leg, is known as deep vein thrombosis . Veins are responsible for taking oxygen-poor blood back to the heart. So what happens when a clot is in the way? (Source: Daily Express - Health)
Source: Daily Express - Health - March 20, 2022 Category: Consumer Health News Source Type: news

Thrombosis Management and the Female Patient Thrombosis Management and the Female Patient
Medscape Medical Affairs (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 16, 2022 Category: Consumer Health News Tags: None Virtual Symposium Source Type: news

Risk for Blood Clots After COVID - 19 Vaccination Explored
Two studies show increase in intracranial venous thrombosis, thrombocytopenia for those younger than 70 years and in CVST after ChAdOx1 - S (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 11, 2022 Category: Cancer & Oncology Tags: Family Medicine, Infections, Internal Medicine, Oncology, Pharmacy, Journal, Source Type: news

Risk for Blood Clots After COVID-19 Vaccination Explored
FRIDAY, March 11, 2022 -- There is a small increased risk for intracranial venous thrombosis, thrombocytopenia, and cerebral venous sinus thrombosis (CVST) after the ChAdOx1-S COVID-19 vaccination, but not after the BNT162b2 vaccination, according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 11, 2022 Category: Pharmaceuticals Source Type: news

Blood clots: Four 'important signs' of deep vein thrombosis – 'Alert your doctor'
BLOOD CLOTS can follow hospitalisation for illness or surgery, including a hip or knee replacement, as well as confinement to a wheelchair, or long-term heart disease. (Source: Daily Express - Health)
Source: Daily Express - Health - March 4, 2022 Category: Consumer Health News Source Type: news

Lower Extremity Motor Weakness Affects DVT in Lumbar Surgery Lower Extremity Motor Weakness Affects DVT in Lumbar Surgery
Lumbar surgery patients with motor weakness may be more at risk for the development or exacerbation of perioperative deep vein thrombosis.Spine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 23, 2022 Category: Consumer Health News Tags: Orthopaedics Journal Article Source Type: news